Thalidomide protects mice against LPS-induced shock
Braz. j. med. biol. res
;
30(10): 1199-207, Oct. 1997. ilus, graf
Artigo
em Inglês
| LILACS
| ID: lil-201538
ABSTRACT
Thalidomide has been shown to selectively inhibit TNF-alpha production in vitro by lipopolysaccharide (LPS)-stimulated monocytes. TNF-alpha has been shown to play a pivotal role in the pathophysiology of endototoxic shock. Using a mouse model of LPS-induced shock, we investigated the effects of thalidomide on the introduction of TNF-alpha and other cytokines and on animal survival. After injecton of 100-350 mug LPS into mice, cytokines including TNF-alpha, IL-6, IL-10, IL-1beta, GM-CSF and IFN-gamma were measured in the serum. Administration of 200 mg/kg thalidomide to mice before LPS challenge modified the profile of LPS-induced cytokine secretion. Serum TNF-alpha levels were reduced by 93 percent, in a dose-dependent manner, and TNF-alpha mRNA expression in the spleens of mice was reduced by 70 percent. Serum IL-6 levels were also inhibited by 50 percent. Thalidomide induced a two-fold increase in serum IL-10 levels. Thalidomide treatment did not interfere with the production of GM-CSF, IL-1beta or IFN-gamma. The LD50 of LPS in this model was increased by thalidomide pre-treatment from 150 mug to 300 mug in 72 h. Thus, at otherwise lethal doses of LPS, thalidomide treatment was found to protect animals from death.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Choque Séptico
/
Talidomida
/
Lipopolissacarídeos
/
Modelos Animais de Doenças
Limite:
Animais
Idioma:
Inglês
Revista:
Braz. j. med. biol. res
Assunto da revista:
Biologia
/
Medicina
Ano de publicação:
1997
Tipo de documento:
Artigo
/
Documento de projeto
Similares
MEDLINE
...
LILACS
LIS